Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
BackgroundThe impact of renin-angiotensin system inhibitors (RASIs) on the outcome of hypertensive cancer patients undergoing immune checkpoint inhibitor (ICIs) therapy remains ambiguous. This investigation sought to elucidate the consequences of RASIs use on the prognosis for this specific patient...
Saved in:
Main Authors: | Junjie Yu (Author), Fangang Meng (Author), Wenxia Sui (Author), Junmin Yu (Author), Jinhai Shen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?
by: Nadiya Hussain, et al.
Published: (2021) -
Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies
by: Jingli Lu, et al.
Published: (2019) -
New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
by: Atsuhiro Ichihara, et al.
Published: (2010) -
Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study
by: Youngkwon Jo, et al.
Published: (2022) -
Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
by: Babak Saravi, et al.
Published: (2021)